Search clinical trials for: Wee-1 kinase inhibitor AZD1775
Total 11911 results
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawn
-
Shi MingSuspended
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Steroid Refractory Graft Versus Host DiseaseUnited States
-
Sun Yat-sen UniversityWithdrawn
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States
-
Beijing Friendship HospitalCompleted
-
GlaxoSmithKlineCompleted
-
Xinqiao Hospital of ChongqingNot yet recruitingSubacute Thyroiditis
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkCompletedCarcinoid Tumor | Neuroendocrine Neoplasm | Metastatic Carcinoid TumorUnited States
-
Emory UniversityTerminatedRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Ariad PharmaceuticalsCompletedChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)Japan
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerSpain, United States, Canada, France, United Kingdom
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Rearrangement | ALK Gene Translocation | ALK...United States, Guam, Puerto Rico
-
ParaPRO LLCCompletedPediculosis Capitis (Head Lice)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedGraft-Versus-Host Disease (GVHD) Acute on ChronicUnited States
-
Yale UniversityPfizerCompletedCutaneous Sarcoidosis | Granuloma AnnulareUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownHepatitis B, ChronicTaiwan
-
University of Alabama at BirminghamWithdrawnCarcinosarcoma of Ovary | Carcinosarcoma of Uterus | Carcinosarcoma of VaginaUnited States
-
Dong WangNot yet recruiting
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; The First Affiliated Hospital... and other collaboratorsWithdrawnHepatocellular CarcinomaChina
-
CSL BehringRecruitingAcute-graft-versus-host DiseaseUnited States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Michael Campos, MDCSL BehringCompletedAlpha 1 Antitrypsin DeficiencyUnited States
-
Li Xiao WeiNot yet recruitingHepatocellular Carcinoma With PVTTChina
-
Fujian Cancer HospitalRecruiting
-
Ruijin HospitalActive, not recruitingGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Baptist Health South FloridaBeiGeneRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Secondary Central Nervous System LymphomaUnited States
-
Emory UniversityEisai Inc.TerminatedDifferentiated Thyroid Gland Carcinoma | Thyroid Gland Follicular Carcinoma | Thyroid Gland Papillary CarcinomaUnited States
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaboratorsRecruitingMetastatic Renal Cell CarcinomaChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Fudan UniversityRecruitingCarcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKIChina
-
Peking University Cancer Hospital & InstituteUnknownAdvanced Mucosal MelanomaChina
-
LaNova Medicines LimitedTerminated
-
Genentech, Inc.Completed
-
Spanish Lung Cancer GroupCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in... and other conditionsCanada
-
Sun Yat-sen UniversityNot yet recruitingEndometrial Cancer | Endometrial AdenocarcinomaChina
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Untreated Chronic Lymphocytic LeukemiaUnited States
-
PfizerCompletedHealthy VolunteerUnited States
-
Hebei Medical University Fourth HospitalCompleted
-
University of RochesterTerminatedEsophageal CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteAstraZenecaWithdrawn
-
Tata Memorial HospitalRecruitingCarcinoma, HepatocellularIndia
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States
-
Jinling Hospital, ChinaRecruitingNeoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital DiseasesChina
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States